Bull/Bear Index 47.5/100
→
분할 후 24일 만에 거래 재개. 삼성바이오로직스와 삼성에피스 주가는? 성장 잠재력은? 각각 71%, 25% 상승 예상.
Key takeaway
"분할 후 24일 만에 거래 재개. 삼성바이오로직스와 삼성에피스 주가는? 성장 잠재력은? 각각 71%, 25% 상승 예상." — BullBear's AI rates this story as a mixed, direction-neutral signal, with a market-impact score of 0 out of 100. Reported by Google News Stock Market on November 23, 2025. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Get the next high-impact catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 49.3%.
Join Telegram channel
or scan with phone →